Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $30.00 ($300,000)
  2. 4 Open-market sale CEO and Chairman sold 49,540 shares at an average $27.99 ($1,386,524)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale Chief Financial Officer sold 15,000 shares at an average $24.47 ($367,029)
  5. 4 Grant or award Chief Technical Officer acquired 50,000 shares (grant or award)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale CEO and Chairman sold 16,680 shares at an average $22.50 ($375,236)
  9. 8-K Event Regulation FD disclosure
  10. 4 Open-market sale Chief Financial Officer sold 15,000 shares at an average $24.58 ($368,679)
  11. 10-K Report Annual Report
  12. 8-K Event Results of operations
  13. 4 Open-market sale President sold 85,000 shares at an average $33.57 ($2,853,294)
  14. 4 Open-market sale Chief Scientific Officer sold 7,400 shares at an average $33.46 ($247,578)
  15. 4 Open-market sale Chief Scientific Officer sold 25,900 shares at an average $31.76 ($822,679)
  16. 4 Open-market sale President sold 80,000 shares at $33.00 ($2,640,000)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 36 of 42 · 837 filings